Pentra DX Nexus Hematology Analyzer
Overview Autoloader with continuous loading capability Rack compatibles with most pre and post analytical systems Automatic reflex testing Double DIFF Matrix Body fluids Expert validation station DHSS* technology (*HORIBA Medical Patent) Features Methods of measurement: flow cytometry, Cytochemistry, Impedance, absorbance, Optical cytometry and fluoro-flowcytometry QuaDimension concept : automatic corre…
The supplier does not provide quotations for this product through SelectScience. You can search for similar products in our Product Directory.
Overview
- Autoloader with continuous loading capability
- Rack compatibles with most pre and post analytical systems
- Automatic reflex testing
- Double DIFF Matrix
- Body fluids
- Expert validation station
- DHSS* technology
(*HORIBA Medical Patent)
Features
- Methods of measurement: flow cytometry, Cytochemistry, Impedance, absorbance, Optical cytometry and fluoro-flowcytometry
- QuaDimension concept : automatic correction of the leucocyte count based on 4 independent principles
- DHSS: focused flow cytometry and sequential measurement (impedance and absorbance)
- Automatic reflex testing: selective and programmable (hematology parameters, alarms and flags, demography)
- Rack rotation mixing of samples: smooth and efficient
- Quality: complete traceability for each run in compliance with the accreditation requirements
Horiba Pentra DX Nexus – Clinical Case Study: Normal Patient
The Pentra DX Nexus is the high-throughput hematology analyzer from Horiba Medical. This state-of-the art analyzer uses 5 recognised measurement parameters for differentiation and quantification of hematopoietic populations. This case study is the first in a series of twelve, and gives histograms and differential plots found in a normal patient sample.
Horiba Pentra DX Nexus – Clinical Case Study: Atypical Lymphocytes
The Pentra DX Nexus is the high-throughput hematology analyzer from Horiba Medical. This state-of- the art analyzer uses 5 recognised measurement parameters for differentiation and quantification of hematopoietic populations. This case study is the second in a series of twelve, and gives differential plots, parameter flags and morphological analysis of a patient with atypical lymphocytes.
Horiba Pentra DX Nexus – Clinical Case Study: Acute Myeloid Leukemia
The Pentra DX Nexus is the high-throughput hematology analyzer from Horiba Medical. This state-of- the art analyzer uses 5 recognised measurement parameters for differentiation and quantification of hematopoietic populations. This case study is the third in a series of twelve, and gives differential plots, parameter flags and morphological analysis of a patient with AML.
Horiba Pentra DX Nexus – Clinical Case Study: B-Cell Prolymphocytic Leukemia
The Pentra DX Nexus is the high-throughput hematology analyzer from Horiba Medical. This state-of- the art analyzer uses 5 recognised measurement parameters for differentiation and quantification of hematopoietic populations. This case study is the fourth in a series of twelve, and gives differential plots, parameter flags and morphological analysis of a patient with B-cell Prolymphocytic Leukemia.
Horiba Pentra DX Nexus – Clinical Case Study: Chronic Lymphoid Leukemia
The Pentra DX Nexus is the high-throughput hematology analyzer from Horiba Medical. This state-of- the art analyzer uses 5 recognised measurement parameters for differentiation and quantification of hematopoietic populations. This case study is the fifth in a series of twelve, and gives differential plots, parameter flags and morphological analysis of a patient with CLL.
Horiba Pentra DX Nexus – Clinical Case Study: Chronic Myeloid Leukemia
The Pentra DX Nexus is the high-throughput hematology analyzer from Horiba Medical. This state-of- the art analyzer uses 5 recognised measurement parameters for differentiation and quantification of hematopoietic populations. This case study is the sixth in a series of twelve, and gives differential plots, parameter flags and morphological analysis of a patient with CML.
Horiba Pentra DX Nexus – Clinical Case Study: Follicular Non Hodgkin Lymphoma
The Pentra DX Nexus is the high-throughput hematology analyzer from Horiba Medical. This state-of- the art analyzer uses 5 recognised measurement parameters for differentiation and quantification of hematopoietic populations. This case study is the seventh in a series of twelve, and gives differential plots, parameter flags and morphological analysis of a patient with Follicular Non Hodgkin Lymphoma.
Horiba Pentra DX Nexus – Clinical Case Study: Immature Granular Population
The Pentra DX Nexus is the high-throughput hematology analyzer from Horiba Medical. This state-of- the art analyzer uses 5 recognised measurement parameters for differentiation and quantification of hematopoietic populations. This case study is the eighth in a series of twelve, and gives differential plots, parameter flags and morphological analysis of a patient with an immature granular population.
Horiba Pentra DX Nexus – Clinical Case Study: Red Blood Cells Morphology
The Pentra DX Nexus is the high-throughput hematology analyzer from Horiba Medical. This state-of- the art analyzer uses 5 recognised measurement parameters for differentiation and quantification of hematopoietic populations. This case study is the ninth in a series of twelve, and gives histograms, flags and morphological analysis of an 80 year old patient with abnormal red cell parameters.
Horiba Pentra DX Nexus – Clinical Case Study: Multiple Myeloma
The Pentra DX Nexus is the high-throughput hematology analyzer from Horiba Medical. This state-of- the art analyzer uses 5 recognised measurement parameters for differentiation and quantification of hematopoietic populations. This case study is the tenth in a series of twelve, and gives differential plots, parameter flags and morphological analysis of a patient with Multiple Myeloma.
HORIBA Medical haemostasis instrument validated for use with UK NEQAS BC samples
The Yumizen G200 has been confirmed as suitable for blood coagulation external quality assessment testing
